FRHC vs ZION

FRHC exhibits a severe disconnect between its market price and fundamental value, highlighted by a Piotroski F-Score of 4/9 (Stable/Weak) and a Graham Number of $3.2 against a current price of $151.15. The company is currently trading at an astronomical P/E ratio of 7557.50, while reporting negative YoY revenue growth (-14.10%) and dismal profitability metrics (ROE of 0.22%). Despite a positive 5-year price trajectory, recent quarterly earnings have consistently missed estimates with an average surprise of -129.39%, suggesting a bubble-like valuation unsupported by current cash flow or earnings power.

ZION presents a stark contrast between deep valuation discounts and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($83.55) and Intrinsic Value ($189.98), the low health score and bearish insider sentiment suggest underlying operational risks. Strong year-over-year earnings growth of 38.10% provides a bullish catalyst, but this is offset by a high PEG ratio of 4.29 and a very bearish technical trend. The overall outlook is neutral as the valuation margin of safety battles fundamental fragility.